Source:http://linkedlifedata.com/resource/pubmed/id/20139293
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-2-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1468-2079
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
260-1
|
pubmed:meshHeading |
pubmed-meshheading:20139293-Fibrinolytic Agents,
pubmed-meshheading:20139293-Humans,
pubmed-meshheading:20139293-Injections, Intraocular,
pubmed-meshheading:20139293-Macular Degeneration,
pubmed-meshheading:20139293-Retinal Hemorrhage,
pubmed-meshheading:20139293-Tissue Plasminogen Activator,
pubmed-meshheading:20139293-Visual Acuity
|
pubmed:year |
2010
|
pubmed:articleTitle |
Management of submacular haemorrhage in age-related macular degeneration with intravitreal tenecteplase.
|
pubmed:publicationType |
Letter,
Clinical Trial,
Research Support, Non-U.S. Gov't
|